Efficient inhibition of SARS-CoV-2 emerging EG.5, EG.5.1 and BA.2.86 variants by fusion inhibitor HY3000 peptide
Lili Wu, Anqi Zheng, Yangming Tang, Xiaoyun Wang, Gao Yue, Wenwen Lei, Guizhen Wu, Qihui Wang, George F. Gao
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Virology2019-20 coronavirus outbreakFusionPeptideChemistryMedicineBiochemistryInternal medicinePhilosophyLinguisticsOutbreakInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesComputational Drug Discovery Methods